The Drug Industry and the Pharmacy Benefit Management Companies (PBMs) in 1995 Case Solution
Abstract:
The case briefly explains the economics of the pharmaceutical industry, the circulation of drugs in the United States (and Europe) and occasions worrying the acquisition by pharmaceutical companies of pharmacy benefit administration (PBM) companies.
Pedagogical Goals:
The case concentrates on intention for straight-up combination, the usage of raising competitors ' expenses as a tactical weapon, and the effect of policy on the competitive benefit of companies.
This is just an excerpt. This case is about Strategy
published: 01 Jan 1995
Related Case Solutions & Analyses:
Affinity Plus (A)
Note on Customer Management
Using Aggregate Project Planning to Link Strategy Innovation and the Resource Allocation Process
Overview of E-Business Pricing Models
American Cyanamid (A) & (B) (Combined)
Gree, Inc. Case
Pak Elektron Limited: Converting Systems to ERP
Lululemon Athletica’s Product, Employee and Public Relations Issues
Archer Daniels Midland: Direction and Strategy
Regulatory Reform at OSHA (B)
